scholarly journals An Anti-Inflammatory Role for NLRP10 in Murine Cutaneous Leishmaniasis

2017 ◽  
Vol 199 (8) ◽  
pp. 2823-2833 ◽  
Author(s):  
Gwendolyn M. Clay ◽  
Diogo G. Valadares ◽  
Joel W. Graff ◽  
Tyler K. Ulland ◽  
Richard E. Davis ◽  
...  
Cytokine ◽  
2009 ◽  
Vol 48 (1-2) ◽  
pp. 65
Author(s):  
Ricardo Goncalves ◽  
Xia Zhang ◽  
David M. Mosser

2020 ◽  
Vol 88 (5) ◽  
Author(s):  
María J. Gómez-Zafra ◽  
Adriana Navas ◽  
Jimena Jojoa ◽  
Julieth Murillo ◽  
Camila González ◽  
...  

ABSTRACT Localized skin lesions are characteristic of cutaneous leishmaniasis (CL); however, Leishmania (Viannia) species, which are responsible for most CL cases in the Americas, can spread systemically, sometimes resulting in mucosal disease. Detection of Leishmania has been documented in healthy mucosal tissues (conjunctiva, tonsils, and nasal mucosa) and healthy skin of CL patients and in individuals with asymptomatic infection in areas of endemicity of L. (V.) panamensis and L. (V.) braziliensis transmission. However, the conditions and mechanisms that favor parasite persistence in healthy mucosal tissues are unknown. In this descriptive study, we compared the cell populations of the nasal mucosa (NM) of healthy donors and patients with active CL and explored the immune gene expression signatures related to molecular detection of Leishmania in this tissue in the absence of clinical signs or symptoms of mucosal disease. The cellular composition and gene expression profiles of NM samples from active CL patients were similar to those of healthy volunteers, with a predominance of epithelial over immune cells, and within the CD45+ cell population, a higher frequency of CD66b+ followed by CD14+ and CD3+ cells. In CL patients with molecular evidence of Leishmania persistence in the NM, genes characteristic of an anti-inflammatory and tissue repair responses (IL4R, IL5RA, POSTN, and SATB1) were overexpressed relative to NM samples from CL patients in which Leishmania was not detected. Here, we report the first immunological description of subclinically infected NM tissues of CL patients and provide evidence of a local anti-inflammatory environment favoring parasite persistence in the NM.


2016 ◽  
Vol 13 (2) ◽  
pp. 143-152 ◽  
Author(s):  
Vanessa Ribeiro Figliuolo ◽  
Suzana Passos Chaves ◽  
Luiz Eduardo Baggio Savio ◽  
Maria Luiza Prates Thorstenberg ◽  
Érika Machado Salles ◽  
...  

Apmis ◽  
2017 ◽  
Vol 125 (3) ◽  
pp. 249-258 ◽  
Author(s):  
Nahid Maspi ◽  
Fatemeh Ghaffarifar ◽  
Zohreh Sharifi ◽  
Abdolhossein Dalimi ◽  
Mohammad Saaid Dayer

Vaccine ◽  
2001 ◽  
Vol 19 (25-26) ◽  
pp. 3369-3375 ◽  
Author(s):  
Sima Rafati ◽  
Ali-Hatef Salmanian ◽  
Tahere Taheri ◽  
Manije Vafa ◽  
Nicolas Fasel

2010 ◽  
Vol 52 (2) ◽  
pp. 95-100 ◽  
Author(s):  
Joshua M. Mutiso ◽  
John C. Macharia ◽  
Rosemary M. Mutisya ◽  
Evans Taracha

Formalin-killed promastigotes (FKP) of Leishmania major, in combination with Montanide ISA 720 (MISA), BCG or alum were used in vaccination of an inbred murine model against cutaneous leishmaniasis (CL). Significant and specific increases in anti-FKP IgG responses were detected for both alum-FKP and BCG-FKP compared to MISA-FKP (p < 0.001). Significant increases in splenic lymphocyte recall proliferation was obtained in the MISA-FKP vaccinated mice compared to alum-FKP or BCG-FKP vaccinated groups (p < 0.01). The highest interferon-γ responses were observed in the BCG-FKP group followed by the MISA-FKP while the alum-FKP gave the least responses. Significantly reduced lesion sizes were obtained in the MISA-FKP group compared to the BCG/alum adjuvants-FKP vaccinated groups. Although the BCG-FKP group showed the highest IFN-γ responses, it failed to control cutaneous lesions. Significant reductions in parasite numbers were observed in the MISA-FKP and BCG-FKP vaccinated groups (p < 0.001). There was a good correlation between parasite burden and IFN-γ level indicating IFN-γ response as a sensitive parameter of the immune status. In conclusion, MISA-FKP is the most efficacious vaccine formulation against murine cutaneous leishmaniasis.


Sign in / Sign up

Export Citation Format

Share Document